Piramal Enterprises’ subsidiary Decision Resources Group (DRG) announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies. Abacus will be part of the Market Access Business Unit at Decision Resources Group which currently includes the brands; Fingertip Formulary, HealthLeaders-InterStudy, PharmaStrat and Pinsonault.
The acquisition of UK-based Abacus by Burlington, Massachusetts-based Decision Resources Group will result in a significant global expansion of Decision Resources Group’s market access capabilities.
Abacus differentiates itself by offering integrated market access solutions across the entire product lifecycle from payer strategy, through technical disciplines such as modeling and systematic review to value communications and health technology assessment (HTA). An in-house multimedia team enables Abacus to differentiate their service offering using innovative software solutions including web, mobile and iPad applications.
“Abacus brings to the table a unique combination of technical excellence and robust, evidence based analysis resulting in solutions that are well-designed to address the needs of our healthcare clients,” said Jim Lang, President of the Market Access Business Unit at Decision Resources Group. Lang continued, “Besides expanding our global market access services and products, the acquisition also allows us to now offer market access capabilities for the medical device and diagnostic industry as well as to significantly expand our commercial support capabilities, with industry-leading mobile communication tools.”
“We are excited to continue our growth as a Decision Resources Group company,” said Simon Howard, CEO of Abacus International.
“We view this acquisition as a major step toward becoming a fully integrated global market access solutions provider. Our team of experienced health economic and market access specialists look forward to incorporating the market and payer research data held by sister companies at Decision Resources Group to improve our payer insight and value communications deliverables.”
The acquisition is part of Decision Resources Group’s overall strategy to acquire and/or build leading brands that can leverage each others thought leadership to create meaningful products and services for the healthcare industry.
“Abacus is an important acquisition in Decision Resources Group’s overall strategy to expand our market access capabilities and offer our clients the most innovative, high-value advisory solutions. It also serves to boost our position in Europe as an important resource for healthcare firms worldwide,” said Peter Hoenigsberg, CEO, Decision Resources Group.
Abacus International will remain headquartered in Bicester, England. Results Healthcare, a division of Results International, acted as advisors to Abacus International.
EP News Bureau – Mumbai
- Advertisement -
